# DEA Has Published the Evidence Against Marijuana Rescheduling > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/dea-has-published-the-evidence-against-marijuana-rescheduling/ > **Published:** 2026-08-21T17:29:11-04:00 | **Last Modified / Clinically Audited:** 2026-09-09T09:57:57-04:00 > **Clinical Summary:** The DEA has released evidence against rescheduling marijuana, highlighting key criteria for safety and efficacy in cannabis medicine. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyDosingMental HealthPainAnxiety Why This Matters This article matters for clinicians and their patients as it discusses the DEA’s evidence against rescheduling marijuana, which could impact its legal status and accessibility. If marijuana were to be rescheduled, it would have implications for [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/), including the ability to prescribe it, understand safe and effective dosing, manage drug interactions and contraindications, and assess adequate toxicology information. This information is crucial for clinicians to provide informed guidance and care to their patients regarding [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/). Clinical Summary The DEA’s publication outlines evidence against rescheduling marijuana, highlighting consistent absorption and bioavailability, safe and effective dosing, potential drug interactions and contraindications, and adequate toxicology data. This information is crucial for clinicians as it underscores the need for continued caution and vigilance when considering cannabis in [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/), emphasizing the importance of ongoing research to better understand its implications for patient safety and treatment outcomes. Dr. Caplan’s Take “While the DEA’s publication presents some compelling evidence against marijuana rescheduling, it’s crucial to acknowledge that our understanding of [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) is still evolving. The findings on consistent absorption, safe dosing, and adequate toxicology are promising, but further human studies are necessary to fully understand drug-interaction risks and contraindications.” – [Dr. Benjamin Caplan](https://cedclinic.com/cannabis-halloween-safety/), MD Clinical Perspective 🔬 Emphasizing the recent DEA publication on marijuana rescheduling, it’s crucial for healthcare providers to acknowledge the complexities involved in this issue. While cannabis demonstrates consistent absorption and bioavailability, its safety and effective dosing remain a subject of ongoing research due to varying potency levels among strains. Significant concerns persist regarding drug-interaction risks and potential contraindications with other medications, particularly those metabolized by the same enzymes as cannabinoids. Moreover, the adequate toxicology profile of cannabis is still being elucidated, with long-term effects and addiction potential yet to be fully understood. In [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/), healthcare providers should exercise caution when considering cannabis as a treatment option. Thorough patient assessments, including medication reviews and risk-benefit discussions, are essential to ensure safe and informed decision-making in the context of individual patient needs and circumstances. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20DEA%20Has%20Published%20the%20Evidence%20Against%20Marijuana%20Rescheduling%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74524)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74524)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20DEA%20Has%20Published%20the%20Evidence%20Against%20Marijuana%20Rescheduling%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74524)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [In the Mix: 31 More Articles — June 23, 2026](https://cedclinic.com/31-cannabis-articles-clinical-relevance-june-23-2026/) - [In the Mix: 37 More Articles — June 22, 2026](https://cedclinic.com/mixed-cannabis-industry-articles-june-22-2026/) - [Smart Approach to Marijuana Challenges Medicare Hemp Program Litigation](https://cedclinic.com/medicare-hemp-program-litigation-cbd-coverage-challenge/) 📰 Source: [https://www.morningstar.com/news/accesswire/1210435msn/dea-has-published-the-evidence-against-marijuana-rescheduling](https://www.morningstar.com/news/accesswire/1210435msn/dea-has-published-the-evidence-against-marijuana-rescheduling) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).